Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma 7 Lymphoma, Large B-Cell, Diffuse 6 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Extranodal NK-T-Cell 5 Hodgkin Disease 5 Recurrence 4 Neuroblastoma 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Burkitt Lymphoma 4 Waldenstrom Macroglobulinemia 3 Testicular Neoplasms 3 Sezary Syndrome 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large-Cell, Anaplastic 3 Leukemia, Myeloid, Acute 3 Leukemia, Hairy Cell 3 Dendritic Cell Sarcoma, Interdigitating 3 Central Nervous System Neoplasms 3 Teratoma 2 Sarcoma 2

Interventions

Drug Therapy 2 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Small Cell Lung Cancer Limited Stage × Etoposide × Clear all

NCT03214003 2023-06-22

TRISS

Peking University Cancer Hospital & Institute

Phase NA Completed

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡